Medvarsity Logo
Thumbnail for Pancreatic Cancer: Who Benefits from Surgery? A Practical Approach

CASE DISCUSSION

Pancreatic Cancer: Who Benefits from Surgery? A Practical Approach

India flagPresented India by Dr. Sanjoy Mandal

Views

0

Case Description

Pancreatic cancer presents significant challenges in diagnosis, treatment planning, and surgical decision-making. This webinar explores a practical, evidence-based approach to identifying patients who are most likely to benefit from surgical intervention. The session will focus on assessing tumor...

Case Summary

  • Pancreatic ductal adenocarcinoma remains a highly lethal malignancy where long-term outcomes hinge on accurate staging, tumor biology, and appropriate patient selection for surgery. Anatomically, eighty percent of tumors arise in the pancreatic head, presenting earlier with obstructive jaundice and gastric outlet obstruction, while body and tail lesions typically present late with metastatic spread. Comprehensive evaluation mandates high-resolution pancreatic-protocol contrast-enhanced computed tomography, baseline carbohydrate antigen nineteen-nine levels, and assessment of patient performance status. Disease is categorized into resectable, borderline resectable, locally advanced, and metastatic stages.

Speaker Profile

Dr. Sanjoy Mandal

Dr. Sanjoy Mandal

Senior Consultant, Oncosurgeon, AMR Hospitals, Kolkata

Disclosures

Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.